Test Price
2,800 AED✅ Home Collection Available
HS6ST1 Gene Hypogonadotropic Hypogonadism Type 15 (With/Without Anosmia) Genetic Test
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity and Specificity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Comprehensive telephonic post-test clinical guidance provided for accurate result interpretation and familial risk counseling.
- Insurance Support: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The HS6ST1 Gene NGS test utilizes Next-Generation Sequencing to definitively diagnose Type 15 Hypogonadotropic Hypogonadism, a genetic disorder affecting pubertal development and fertility, often associated with anosmia (Kallmann syndrome). This targeted analysis identifies clinically actionable variants, empowering precise medical management for patients across the UAE.
| Feature | Our Test (DHA-Licensed) | Closest Alternative |
|---|---|---|
| Precision / Methodology | Full Gene NGS Sequencing (99.9% Coverage) | Panel Sequencing or Single Exon Analysis |
| Clinical Utility | Comprehensive Variant Detection (SNVs, Indels) | Limited to predefined hot-spots |
| Turnaround Time | 3 to 4 Weeks | 6 to 8 Weeks (Standard) |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I recognize that the journey to a confirmed genetic diagnosis for hypogonadotropic hypogonadism is deeply personal and often emotional for patients and families. This test provides a definitive molecular answer, but the results must always be correlated with your full clinical picture, hormone profiles, and imaging studies. I commend you for taking this proactive step toward understanding your reproductive health."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Critical Medication Advisory
⚕️ Critical Medication Advisory
Do not discontinue any prescribed hormonal therapy, including gonadotropins, testosterone, or estradiol, without explicit consultation with your supervising physician. Abrupt cessation can precipitate acute endocrine decompensation.
Patient Safety & Exclusion Criteria
Patient Safety & Exclusion Criteria
Exclusion for Home Collection: Patients with active febrile illness (>38.0°C), acute cardiovascular instability, or those requiring continuous supplemental oxygen are not eligible for home-based phlebotomy and should visit a hospital facility.
Emergency Red Flags: If you experience sudden severe testicular or pelvic pain, visual field disturbances, or profound hypotension, seek immediate emergency medical attention rather than proceeding with a routine genetic test.
Patient FAQ & Clinical Guidance
1. How will this test definitively confirm if my pubertal delay is caused by an HS6ST1 gene mutation?
This NGS test definitively identifies disease-causing variants in the HS6ST1 gene by sequencing its entire coding region, providing a molecular diagnosis for Type 15 Hypogonadotropic Hypogonadism with or without anosmia.
2. What is the clinical utility of carrier screening for relatives in families affected by infertility?
Identifying the familial HS6ST1 variant enables accurate carrier testing for at-risk siblings, guiding reproductive planning and early hormonal intervention to optimize pubertal outcomes.
3. How does the mandated pre-test genetic counseling session protect my family's data privacy in the UAE?
The mandatory pre-test genetic counseling session, conducted under strict adherence to UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensures fully informed consent and explains how your genomic data is anonymized and secured.
UAE Regulatory & Data Privacy Adherence
UAE Healthcare Regulatory Compliance
This service strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic counseling is mandatory and confidential. The laboratory is DHA-licensed (Facility License No. 1143) and ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | HS6ST1 Gene Hypogonadotropic Hypogonadism Type 15 (With/Without Anosmia) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) |
| Methodology Used | Next-Generation Sequencing (NGS) – Full Gene Coverage |
| ICD-10-CM Code | E23.0 (Hypogonadotropic hypogonadism) |
| LOINC Code | 82376-6 (HS6ST1 gene mutation analysis) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians